
AI biotech startup Cheiron launches $8 million seed round - The Korea News Plus
Cheiron is an AI biotech startup that has developed a generative AI platform for drug development. It targets the biopharma market by providing a comprehensive operating system that integrates various data sources to support drug developers. The recent funding will help expand its capabilities and enhance its Life Sciences Knowledge Graph.
AI biotech startup Cheiron launches $8 million seed round The Korea News Plus
| Aug 14, 2026 | MiiHealth AI | $2.8M | — | United States |
| Aug 14, 2026 | Alloy Robotics | $8.0M | Pre-seed | United States |
| Aug 14, 2026 | Zipline | $950.0M | Debt | United States |
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |